Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Gentamicin sulfate
Drug ID BADD_D01017
Description Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364] Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]
Indications and Usage Not Available
Marketing Status approved; vet_approved
ATC Code J01GB03; S03AA06; S01AA11; S02AA14; D06AX07
DrugBank ID DB00798
KEGG ID D01063
MeSH ID D005839
PubChem ID 44134730
TTD Drug ID D0L9UU
NDC Product Code 76420-137; 61919-106; 0404-9865; 0404-9866; 68788-7336; 70518-1323; 51927-1610; 67630-0003; 50090-0569; 0338-0509; 71205-333; 38779-0632; 48866-8256; 17478-284; 24208-580; 45802-046; 45802-056; 45865-672; 63187-764; 0409-1207; 55154-2392; 60758-188; 61919-918; 66267-971; 51552-0775; 50090-2333; 0338-0503; 17478-283; 61314-633; 63187-873; 70518-3628; 71205-560; 42513-0008; 53002-9292; 51662-1597; 63187-163; 63323-010; 0713-0683; 76420-254; 51927-0252; 53002-9290; 0338-0505; 0338-0511; 0713-0682; 62991-1072; 63187-560; 71872-7216; 60592-301; 0338-0507
UNII 8X7386QRLV
Synonyms Gentamicins | Gentamycins | Garamycin | Gentacycol | Gentamicin Sulfate | Sulfate, Gentamicin | Gentamicin Sulfate (USP) | Gentavet | Genticin | G-Myticin | G Myticin | GMyticin | Gentamicin | Gentamycin
Chemical Information
Molecular Formula C21H45N5O11S
CAS Registry Number 1403-66-3
SMILES CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.OS(=O)(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Conjunctivitis11.01.06.012; 06.04.01.002--
Eye irritation06.04.05.003--Not Available
Hallucination19.10.04.003--
Hypersensitivity10.01.03.003--
Skin irritation23.03.04.009--Not Available
Thrombocytopenic purpura01.08.01.003; 23.06.01.007--Not Available
Conjunctival hyperaemia06.04.01.004--Not Available
Conjunctival disorder06.06.02.004--Not Available
Ulcerative keratitis10.02.01.021; 06.04.02.004--
The 1th Page    1    Total 1 Pages